HomePCRX • NASDAQ
add
Pacira Biosciences Inc
Previous close
$23.98
Year range
$18.17 - $27.99
Market cap
1.03B USD
Avg Volume
710.60K
P/E ratio
51.42
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 179.52M | 6.49% |
Operating expense | 108.44M | 19.90% |
Net income | 5.43M | 103.79% |
Net profit margin | 3.03 | 103.56% |
Earnings per share | 0.70 | -11.39% |
EBITDA | 28.84M | -31.65% |
Effective tax rate | 42.97% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 246.33M | -45.72% |
Total assets | 1.30B | -14.73% |
Total liabilities | 570.36M | -26.13% |
Total equity | 727.21M | — |
Shares outstanding | 43.02M | — |
Price to book | 1.42 | — |
Return on assets | 2.32% | — |
Return on capital | 2.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 5.43M | 103.79% |
Cash from operations | 60.83M | 12.82% |
Cash from investing | 43.61M | 183.61% |
Cash from financing | -257.48M | -8,950.12% |
Net change in cash | -152.90M | -13,952.85% |
Free cash flow | 11.54M | -74.39% |
About
Founded
2006
Headquarters
Website
Employees
789
